MedaSystems, a Menlo Park, Calif.-based digital health software company, raised $1.5m in pre-seed funding.
The round was led by nina capital in conjunction with a group of strategic angel investors.
Led by Fiona Smythe, CEO, MedaSystems has developed a networked platform where pharmaceutical manufacturers and healthcare providers can collaborate on Expanded Access (also known as Managed Access or Compassionate Use) requests.
Expanded Access allows patients with a serious or life-threatening condition, who have exhausted the standard of care and are not eligible to participate in clinical trials, to request access to investigational therapies that have not yet gained authorization from local regulatory authorities. Expanded Accesses played an essential role in developing novel treatments during the Covid-19 pandemic and historically has been a vital pathway for patients with conditions such as cancer, ALS, Alzheimer’s disease, and thousands of rare diseases.
The platform enables pharmaceutical companies to respond to Expanded Access requests faster and more efficiently, design more effective clinical trials, enhance pre-approval regulatory submissions and capture real-world data.
FinSMEs
23/03/2022